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Abstract
No detailed data exist in the literature on the accurate diagnosis of chronic brucellar meningitis or meningoencephalitis. A multicentre
retrospective chart review was performed at 19 health centres to determine sensitivities of the diagnostic tests. This study included 177
patients. The mean values of CSF biochemical test results were as follows: CSF protein, 330.64  493.28 mg/dL; CSF/ blood-glucose ratio,
0.35  0.16; CSF sodium, 140.61  8.14 mMt; CSF leucocyte count, 215.99  306.87. The sensitivities of the tests were as follows: serum
standard tube agglutination (STA), 94%; cerebrospinal ﬂuid (CSF) STA, 78%; serum Rose Bengal test (RBT), 96%; CSF RBT, 71%; automated
blood culture, 37%; automated CSF culture, 25%; conventional CSF culture, 9%. The clinician should use every possible means to diagnose
chronic neurobrucellosis. The high seropositivitiy in brucellar blood tests must facilitate the use of blood serology. Although STA should be
preferred over RBT in CSF in probable neurobrucellosis other than the acute form of the disease, RBT is not as weak as expected.
Moreover, automated culture systems should be applied when CSF culture is needed.
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The results of the Istanbul-2 study have not been presented
anywhere.
Introduction
Meningoencephalitis and meningitis were reported to have
been detected in 5% of all brucellosis patients [1]. The
involvement of the central nervous system (CNS) in brucel-
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losis features series of clinical presentations. The clinical
presentations in acute meningitis or meningoencephalitis
typically resemble various forms of CNS infections, cautioning
clinicians to carry out immediate intervention [2,3]. However,
chronic meningitis and meningoencephalitis are major indis-
tinct features of nuerobrucellosis with predominant neuro-
psychiatric changes causing deteriorated ramiﬁcations [4,5].
Despite all efforts in the treatment of the disease, 20% of cases
experiences persistent sequelae [6]. Thus, accurate and timely
diagnosis of the disease is extremely important in the rational
management of patients with neurobrucellosis.
In the diagnosis of CNS infections, bacterial culture is the
reference standard [7]. In contrast, gram-stained smears and
cultures of cerebrospinal ﬂuid (CSF) are often negative in
patients with chronic neurobrucellosis, and diagnosis usually
depends on the presence of speciﬁc antibodies [8,9]. Thus,
alternate methods such as serological tests and molecular
methods are inevitable options [10,11]. Brucella-speciﬁc anti-
bodies are usually not detected in the CSF unless the central
nervous system is involved. However, in neurobrucellosis, CSF
contains low titres of antibodies, which can be detected by
agglutination tests [8]. In addition, the data related to diagnosis
of neurobrucellosis have been restricted to case reports or
small case series in the literature and informative data on this
subject were necessary [12–15]. Thus, the aim of this study
was to determine CSF biochemical values and the sensitivities
of microbiological tests, and their interrelations in chronic
brucellar meningitis/meningeoencephalitis patients.
Methods
The Istanbul study was designed in two steps. The ﬁrst part
related to therapeutic concerns and courses of the disease,
and outcomes were published elsewhere [6]. Thus, the
Istanbul-2 study, targeting diagnostic issues, is presented in
this paper. As a multicentre retrospective chart review, the
Istanbul-2 study was performed in 19 health centres (16
university and three state training hospitals) in Turkey. In this
study, adult patients treated after the year 2000 with a
diagnosis of chronic brucellar meningitis or meningoenceph-
alitis were included. The case deﬁnitions of the study were as
follows [6]: (i) the presence of consistent clinical symptoms
either with meningitis or meningoencephalitis for over
4 weeks to classify the case as chronic; (ii) consistency of
typical CSF ﬁndings with meningitis (protein concentrations
>50 mg/dL, pleocytosis over 10/mm3 and glucose to serum
glucose ratios <0.5 are accepted as abnormal [16]), (iii)
positive bacterial culture or serological test results for
brucellosis in blood specimens (positive Rose Bengal test
(RBT) and serum tube agglutination (STA) with a titre  1/
160) or in CSF (positive RBT or STA with any titre) or positive
bone marrow culture; and (iv) absence of an alternative
neurological diagnosis explaining the clinical presentations.
Patients fulﬁlling these criteria were regarded as having
brucellar meningitis or meningoencephalitis and included in
the study.
The data analysis was performed with SPSS in the Windows
V.15.0 program. Descriptive statistics were presented as
frequencies, percentages for categorical variables and as
mean  standard deviation and median (min–max) for con-
tinuous variables. Before the analysis of titration data,
logarithmic transformation (based on log10) was performed.
In comparing the groups, the chi-square, Mann–Whitney U and
t-tests were used. The agreements between the tests were
evaluated with Kappa coefﬁcient. j value < 0.20 was inter-
preted as poor, 0.20–0.40 as fair, 0.40–0.60 as moderate, 0.60–
0.80 as good and 0.80–1.00 as very good agreement [17]. In
the assessment of the relations between the variables, Pearson
and Spearman correlation coefﬁcients were calculated. In
comparing the sensitivity of the data, p < 0.05 was considered
signiﬁcant.
Results
This study included 177 patients (91 female and 86 male) with
chronic brucellar meningitis or meningoencephalitis. The
median age of the patients was 30 (14–78). The mean values
of CSF biochemical test results were as follows: CSF protein,
330.64  493.28 mg/dL, min–max = 25–3191 mg/dL; CSF/
blood-glucose ratio, 0.35  0.16, min–max = 0.03–0.82; CSF
sodium, 140.61  8.14, min–max = 110–153 mMt; CSF leu-
cocyte count, 215.99  306.87, min–max = 0–2700. In eight
patients (4.5%), no leucocyte was detected on CSF examina-
tion. In six out of eight patients one serological test was
positive; the other patient had three positive serological tests
and the remaining one had four positive serological tests. In
ﬁve out of eight patients CSF culture was found to be positive,
and in one patient blood culture was positive. Various
diagnostic tests were used in this study and the sensitivities
of the microbiological tests performed for the diagnosis are
presented in Table 1.
Serological tests
Serological tests such as serum-STA (n = 172), CSF-STA
(n = 144), serum-RBT (n = 123), CSF-RBT (n = 106), CSF-
Elisa (n = 10) and serum-Elisa (n = 11) were applied to our
patients. In 100 cases, both STA and RBT tests were
performed together in the CSF samples. The STA test was
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performed both in serum and in CSF in 141 cases and RBT was
performed both in serum and in CSF in 104 cases.
Among the eight serological tests applied (CSF-STA, CSF-
RBT, serum-RBT, serum-STA, CSF IgM, CSF-IgG, serum IgM
and Serum IgG), 32 (18.1%) patients had one, 45 (25.4%)
patients had two, 23 (13.0%) patients had three, 64 (36.2%)
patients had four, one (0.6%) patient had ﬁve, three (1.7%)
patients had six, one (0.6%) patient had seven and three
patients (1.7%) had eight with seropositivity. Five patients
did not have any serological evidence. In 105 out of 110
CSF-STA positive test cases, the serum-STA test was also
positive. On the other hand, in all 31 CSF-STA negative
cases, serum-STA was found to be positive. In CSF-STA
positive cases, CSF-RBT was negative in 15 patients.
However, in two CSF-STA negative samples, CSF-RBT was
found to be positive.
Comparison and agreement of serological tests. There was no
signiﬁcant difference between the sensitivities of CSF-RBT and
CSF-STA (p = 0.163), and the serum RBT and the serum-STA
(p = 0.500). Nonetheless, there were differences for either
serum-RBT and CSF-RBT or serum-STA and CSF-STA
(p = 0.006, p < 0.001, respectively). The agreement between
RBT tests either in the serum or CSF was poor (j, 0.137).
Likewise, there was a poor agreement between serum-STA
and CSF-STA tests (j, 0.065). When CSF-STA titres were
correlated with serum-STA titres (r = 0.111, p = 0.261), no
concordance was detected.
Culture process
In this study, CSF culture was not obtained in 38 (21.5%)
patients. Thus, 25.3% of samples were positive (22 of 87) for
automated CSF culture and 8.8% of samples were positive (5 of
52) for conventional CSF culture. Among the ﬁve patients
without serological evidence, three had CSF culture and two
had blood culture positivity. The difference between these two
culture techniques was statistically signiﬁcant (p = 0.013). The
agreement between the automated CSF and automated blood
culture positivity was poor and their sensitivities did not differ
statistically (p = 0.463, j = 0.048). The interrelations
between the culture methods are presented in Table 2.
The interrelations between laboratory tests
● STA titres and RBT: The mean CSF-STA titres were
signiﬁcantly higher in CSF-RBT positive cases (1/155.48
(log10: 1.88  0.50), median = 1/160) than in CSF-RBT
negative cases (1/21.20 (log10:1.26  0.21), median = 1/
20) (p < 0.001). The distribution of CSF-STA titres
according to RBT results is presented in Table 3. On the
other hand, the mean serum-STA titres were not signif-
icantly different in CSF-RBT positive cases (1/717.22
(log10:2.71  0.36), median = 1/640) than in CSF-RBT
negative cases (1/597.04 (log10:2.63  0.40), median = 1/
320) (p = 0.380).
● Agreement of CSF culture with serology: There was no
signiﬁcant difference for CSF-STA test positivity between
automated CSF culture positives (n, 14/17; 82.4%) and
negatives (n, 49/62; 79%) (p = 1.000). CSF-RBT was found
to be positive in 18 of the 19 automated CSF culture
positive (95%) patients and in 44 out of 46 (95%)
automated CSF culture negative patients. There was a
poor agreement between automated CSF culture and CSF-
RBT tests (j, 0.006). In automated CSF culture positive
and negative patients there were poor agreements
between positive serum-STA and CSF-STA test results
(j, 0.103 and 0.031, respectively).
TABLE 1. The sensitivities of the microbiological tests in
chronic neurobrucellosis
Total Positive Sensitivity %
Serum STA 172 162 94.2
CSF STA 144 113 78.5
Serum RBT 123 118 95.9
CSF RBT 106 75 70.8
Blood culture (Bactec, BacTAlert) 154 57 37
CSF culture (Bactec, BacTAlert) 87 22 25.3
CSF culture (conventional method) 52 5 9.5
CSF-Elisa (IgM) 10 8 80
CSF-Elisa (IgG) 10 8 80
Serum-Elisa (IgM) 11 7 70
Serum-Elisa (IgG) 11 10 91
BM culture (Bactec, BacTAlert) 8 3 37
CSF, cerebrospinal ﬂuid; RBT, Rose-Bengal test; STA, standard tube agglutination
test; BM, bone marrow.
TABLE 2. The interrelations between the culture methods in chronic neurobrucellosis
Cultures
Conventional CSF Automated CSF Blood
Pos Neg Total Pos Neg Total Pos (%) Neg (%) Total
Conventional CSF, (n = 52) Pos 0 () 0 () 0 3 (60) 2 (40) 5
Neg 1 () 0 () 1 16 (34.8) 30 (65.2) 46
Automated CSF (n = 87) Pos 10 (45.5) 12 (54.5) 22
Neg 23 (35.9) 41 (64.1) 64
Pos, positive; Neg, negative.
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● CSF-STA titers and CSF culture: The CSF-STA titres were
signiﬁcantly lower in CSF culture positive patients
(log10:1.50  0.48 (mean titre, 1/61.75)) than in culture
negative patients (log10:2.08  0.59 (mean titer, 1/372.98))
(p < 0.001).
● Serum-STA titres and CSF culture: However, there was no
signiﬁcant difference for serum-STA titres between culture
positive patients (1/627.37 (log10:2.63  0.39)) and nega-
tive patients (1/675.48 (log10:2.68  0.36)) in automated
CSF culture (p = 0.614). Accordingly, there was no
signiﬁcant difference for serum-STA titres between culture
positive patients (1/480.00 (log10:2.56  0.35)) and nega-
tive patients (1/600.00 (log10:2.57  0.43)) in conventional
CSF culture (p = 0.913).
● CSF-STA titres and blood culture: The mean CSF-STA titre was
1/305.28 (log10:1.94  0.61) in blood culture negative patients
and 1/300.06 (log10:1.94  0.64) in blood culture positive
patients. The association was statistically insigniﬁcant
(p = 0.989).
● CSF-STA titres and biochemical tests: There was a statistically
signiﬁcant, moderate, negative correlation between CSF-
STA titres and CSF protein (r = 0.241, p = 0.010).
When the CSF-STA titres were correlated with CSF/
blood-glucose ratios (r = 0.056, p = 0.558), no signiﬁcance
was detected. When the CSF-STA titres were correlated
with CSF leucocyte counts (r = 0.014, p = 0.888), no
signiﬁcance was detected.
● The interrelations between biochemical tests: There was a
statistically signiﬁcant, moderate, but inverse correlation
between CSF leucocyte counts and CSF/blood-glucose
ratios (n, 156; r = 0.420; p < 0.001). A statistically
signiﬁcant, fair and negative correlation between CSF
protein levels and CSF/blood-glucose ratios was detected
(r = 0.338, p < 0.001). There was a signiﬁcant and fair
correlation between CSF leucocyte counts and CSF
protein levels (r = 0.243, p = 0.002). The interrelations
between the laboratory analyses are presented in Table 4.
Correlation of laboratory tests and patient demographics
ThemeanCSF-STA titreswerenot signiﬁcantly different between
male patients (1/220.30 (log10:2.34  0.546) min–max = 1/8–1/
2560) and female patients (1/342.42 (log10:2.53  0.66) min–
max = 1/8–1/5120) (p = 0.196). Accordingly, there was no
signiﬁcant difference between male patients (1/727.89
(log10:2.69  0.40), min–max = 1/40–1/2560) and female
patients (1/611.16 (log10:2.61  0.40), min–max = 1/40–1/
2560) for serum-STA titres (p = 0.234). No signiﬁcant correla-
tionwas detected between the age of the patients and serum-STA
titres (r,0.1; p = 0.205), CSF-STA titres (r,0.038; p = 0.692),
CSF protein levels (r,0.052; p = 0.513) and CSF/blood-glucose
ratios (r, 0.010; p = 0.903). However, there was a weak and
inverse correlation between increasing age and CSF leucocyte
counts (r, 0.163; p = 0.041).
Discussion
Neurobrucellosis, which mainly presents as meningitis or
meningoencephalitis, is a differential diagnostic challenge for
clinicians. In our study, neither automated nor conventional
CSF cultures were taken in one-ﬁfth of the patients. This was
probably due to the chronic and relatively silent nature of the
disease compared with purulent meningitis. Furthermore,
inexperienced clinicians may not consider the culture process,
TABLE 3. The distribution of CSF-
STA titres according to RBT and
culture results
STA titres
CSF-STA
(n)
CSF-RBT
Conventional
CSF culture
Automated
CSF culture
Pos
(n)
Neg
(n)
Pos
(n)
Neg
(n)
Pos
(n)
Neg
(n)
 1/20 26 8 14 (n = 2) 4 6 6
<1/20–1/40 17 15 1 () 4 4 4
<1/40–1/80 25 18 () () 12 1 10
<1/80–1/160 23 16 () () 9 2 12
<1/160–1/320 12 8 () () 4 1 7
<1/320–1/640 4 3 () () () () 4
<1/640–1/1280 1 () () () () () 1
<1/1280 5 1 () () () () 5
Overall positives 113 69 15 2 33 14 49
Untested 33 4 2 2 10 5 4
Negative 31 2 14 1 9 3 13
Total 177 75 31 5 52 22 66
TABLE 4. The correlation between the laboratory data
during chronic neurobrucellosis
Serum STA
titres
CSF/Blood
glucose
CSF leucocyte
counts
CSF-STA titres r = 0.111,
p = 0.261
r = 0.056,
p = 0.558
r = 0.014,
p = 0.888
CSF leucocyte
Counts
r =0.420,
p < 0.001a
CSF protein r = 0.338,
p < 0.001a
r = 0.243,
p = 0.002b
aStatistically signiﬁcant, moderate and inverse correlation.
bStatistically signiﬁcant and moderate correlation.
Signiﬁcance of bold value is p < 0.05.
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but serology, for the differential diagnosis of this unexplained
brain disorder, leading to the subsequent establishment of the
neurobrucellosis diagnosis. On the other hand, although
positive bacterial culture is the reference standard for
diagnosis of infectious diseases, it has been demonstrated to
be suboptimal in neurobrucellosis [18,19]. The increased
efﬁcacy of automated blood culture systems has been advo-
cated by some authors in other forms of chronic meningitis, as
in tuberculosis [20]. Accordingly, automated blood culture
systems have been reported to improve the recovery speed of
the Brucella strains from the blood [21]. The sensitivity of
automated blood culture systems was reported to be 80–100%
positive in brucellosis [22,23]. These systems were known to
be reliable in the isolation of the pathogen within 5–7 days
[24,25]. To the authors’ knowledge, nothing is noted in the
literature on the efﬁcacy of automated blood culture systems
in the isolation of Brucella species from the CSF in neurobru-
cellosis patients. In our study, conventional bacterial culture
was reproductive in one-tenth of our cases, while automated
systems yielded the pathogen from the CSF in one-ﬁfth of the
patients. Thus, the yield of automated culture was signiﬁcantly
higher than the conventional culture in CSF samples. Accord-
ing to our data, although the association between the
concordant CSF and blood culture yields was poor, their
sensitivities were not substantially different for automated
culture systems. This poor agreement is probably related to
organotropism of the infecting pathogen. In addition to blood
and CSF cultures, the pathogen can be cultured from other
sites of localized disease, including bone marrow. In our study,
in three out of eight patients (37%), Brucella strains were
recovered from the bone marrow specimens.
In automated CSF culture positive patients the detection
rate of the disease by CSF-STA was not higher than in culture
negative patients. However, the titres were signiﬁcantly lower
in the culture-positive group. Higher CSF-STA titres increased
the quantity of antibodies in the CSF, which seems to indicate
the probable clearance of the pathogen due to strong
immunity, leading to high culture negativity. On the other
hand, the CSF isolation of the infecting microorganisms with
either automated or conventional culture methods did not
alter blood STA titres. Conversely, blood culture positivity did
not affect CSF-STA titres. Thus, we found that the agreement
of automated CSF culture with CSF-RBT, serum-STA and CSF-
STA tests was poor, indicating the different kinetics of
serology and culture.
STA, RBT, ELISA, complement ﬁxation, indirect coombs and
immunecapture agglutination (Brucellacapt) methods have
been used in the serological diagnosis of Brucellosis [26–28].
As culturing of Brucella takes time and is not always reliable,
diagnosis is usually based on these indirect serological tests.
However, because these conventional serological tests lack full
sensitivity and speciﬁcity, there may be discordances between
their results [29]. This was also conﬁrmed with differences
either in CSF or in blood tests in our study. Moreover,
agglutination reactions become positive during the second to
third week of illness [30], and thus our results show the real
sensitivities of serological tests because our patients have a
chronic nature of CNS disease over 4 weeks. According to
our data, serological approaches appear to be the mainstays in
the diagnosis of neurobrucellosis due to the relatively lower
efﬁcacy of bacterial culture. Although the CSF-STA test was
not shown to be statistically superior to CSF-RBT in our data,
probably due to the chronic nature of our patients, CSF-STA
titres were signiﬁcantly higher in CSF-RBT positive patients.
However, this correlation was not established between serum-
STA titres and CSF-RBT. In addition, CSF-RBT remains
negative with lower CSF-STA titres. Accordingly, CSF-RBT
tended to be positive when the CSF-STA titre was equal to or
higher than 1/40. Only in one out of 15 patients with a CSF-
STA titre lower than 1/40, was CSF-RBT found to be positive.
Thus, the 1/40 STA titre seems to be the threshold for CSF-
RBT positivity and CSF-RBT seems inefﬁcient for lower titres
in chronic meningitis or meningoencephalitis; however, in two
CSF-STA negative patients, CSF-RBT was found to be positive.
It is known that there are four IgG subclasses targeting Brucella,
with the IgG4 subclass predominating in three-fourths of
patients with chronic brucellosis, followed by IgG1, IgG2 and
IgG3. The last two were detected in a quarter of the patients
[31]. Basically, RBT has a predilection to detect IgG1 and in
these two aforementioned CSF-STA negative and CSF-RBT
positive patients, the serological proﬁle might be attributed to
this speciﬁc IgG1 positivity or, alternatively, a laboratory error
might have occurred during the evaluation of the CSF-STA test
in these two cases [31,32].
In our study, serum RBT and STA were found to be 95.9%
and 94.2% positive and our data supported the view that blood
serological tests were signiﬁcantly more sensitive than CSF
tests. On the other hand, the agreement between serum-STA
and CSF-STA was poor and the agreement between their
titres for both sites was insigniﬁcant. Accordingly, gender did
not affect STA titres either in the serum or CSF. The same
result was observed for agreement between CSF and serum
RBTs. Moreover, positivity of CSF-RBT did not affect serum-
STA titres. Thus, when the serological responses were
evaluated, CSF and the blood appeared to be the two distinct
sites with different kinetics.
Although the ELISA test was shown to be promising in CNS
Brucellosis [13,33], the sensitivity of this method was not
reported to be higher than that of conventional tests [26]. This
seemed to be the case in our study. On the other hand, CSF
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PCR was not applied to any of our cases, and we could not
present data for PCR. However, in one study real-time PCR
assay was positive in all of six neurobrucellosis cases [14].
According to these preliminary data, molecular diagnostic
methods seem to be promising in the diagnosis and follow-up
of neurobrucellosis [34].
The microbiological evidence of neurobrucellosis has been
known to be accompanied by lymphocytic pleocytosis,
elevated protein levels and hypoglycorrhachia [11,15,35].
Normal CSF values have been accepted to be <50 mg/dL of
protein, a CSF-to-serum glucose ratio >0.6 and leucocyte
counts <5/μL in CNS infections [19,36]. In the initial reports
with small case series of neurobrucellosis, abnormalities of
the cerebrospinal ﬂuid were reported to include a pleocy-
tosis of 10–200 leucocytes [15]. In our study, CSF leucocyte
counts (215.99  306.87) and CSF protein levels (330.64 
493.28 mg/dL) ranged over a wide spectrum and were
apparently higher than expected. Moreover, although the
increased CSF protein levels slightly reduced CSF-to-serum
glucose ratios, leucocyte counts had a moderate effect on
this issue. The pathogenesis of CSF hypoglycorrhachia is
multifactorial and may include an increased glycolysis by
leucocytes and bacteria and increased metabolic rate of the
brain and spinal cord [36]. These data appear to indicate the
effect of an inﬂammatory response on CSF glucose con-
sumption. A similar correlation existed between CSF protein
levels and leucocyte counts, which both increased concor-
dantly. On the other hand, CSF leucocyte counts and CSF/
blood-glucose ratios, as the indicators of inﬂammation and
cellular metabolism, did not affect CSF-STA titres. This is
probably due to the chronic nature of our neurobrucellosis
patients, where STA titres were already established. How-
ever, CSF protein levels altered CSF-STA titres because
Brucella immunoglobulins are one of the direct contributors
to CSF protein, although the effect was moderate, indicating
the presence of other sources.
It is reported that advanced age did not affect CSF
leucocytes, CSF/blood-glucose ratios and CSF protein levels
during the course of acute purulent meningitis in the elderly
population [7]. In this chronic form of CNS disease, the results
were similar, and serum or CSF-STA titres, protein levels and
CSF/blood-glucose ratios were unaffected by ageing. However,
there was a slight decrease in leucocyte counts with advancing
age in our study.
Conclusion
Chronic brucellar meningitis and meningoencephalitis fre-
quently have a subtle nature and cannot be diagnosed easily
due to the relatively silent course of the disease [6]. Thus, the
clinician should use every diagnostic modality available in the
diagnosis of the disease. The high seropositivity in brucellar
blood tests must facilitate the use of blood serology in a
chronic CNS infection in the absence of any aetiological
diagnosis. Moreover, automated culture systems should be
applied when CSF culture is needed in probable neurobrucel-
losis patients with chronic CNS disease.
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